Scientists have identified a promising strategy to improve liver cancer immunotherapy: targeting B-cells. While immunotherapy ...
An expert discusses IL-18-armored CAR T cells for adults with relapsed B-cell leukemia, showing complete remissions with ...
How do high-affinity B cells ever beat the odds? New research now suggests that B cells avoid gambling away good mutations by strategically banking successful ones. As described in Nature, successful ...
Background Withdrawal of prolonged nucleos(t)ide analogue (NA) treatment results in hepatitis B surface antigen (HBsAg) loss in some subjects with chronic hepatitis B (CHB), potentially revealing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback